Coherus Oncology, Inc. Other Current Liabilities
Coherus Oncology, Inc. (CHRS) had Other Current Liabilities of $3.86 million as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2021-02-25
- 2020-12-31: Other Liabilities, Current $3.86M.
- 2020-09-30: Other Liabilities, Current $4.62M.
- 2020-06-30: Other Liabilities, Current $3.63M.
- 2020-03-31: Other Liabilities, Current $2.45M.
| Period end | Other Liabilities, Current |
|---|---|
| 2020-12-31 | $3.86M 10-K · filed 2021-02-25 |
| 2020-09-30 | $4.62M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.63M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.45M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.20M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.04M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.20M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $2.14M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $419.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $402.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $385.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $367.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $341.00K 10-K · filed 2019-02-28 |
| 2017-09-30 | $322.00K 10-Q · filed 2017-11-06 |
| 2017-06-30 | $308.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | $281.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $259.00K 10-K · filed 2018-03-08 |
| 2016-09-30 | $251.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $209.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $205.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $193.00K 10-K · filed 2017-03-14 |
| 2015-09-30 | $223.00K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $62.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $56.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $52.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | $57.00K 10-Q · filed 2014-12-15 |
| 2013-12-31 | $21.00K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |